Cryo Cell International (CCEL) Receivables - Other (2011 - 2026)

Cryo Cell International has disclosed Receivables - Other across 15 years of filings, most recently posting $874564.0 for Q1 2026.

• In Q1 2026, Receivables - Other rose 9.85% year-over-year to $874564.0; the TTM figure through Feb 2026 stood at $874564.0 (up 9.85% YoY), while the FY2025 annual figure was $855142.0, up 10.32% from the prior year.
• Receivables - Other improved to $874564.0 in Q1 2026, from $855142.0 in the prior quarter.
• Over the last five years, Receivables - Other for CCEL reached as high as $10.0 million in Q2 2022 and fell as low as $553116.0 in Q1 2022.
• The 5-year median for Receivables - Other is $738555.0 (2024), against an average of $1.3 million.
• Annual changes were most pronounced in 2022 — Receivables - Other surged 3233.33% — and 2023, when it plunged 93.46%.
• A 5-year view of Receivables - Other shows it stood at $615628.0 in 2022, then rose by 13.01% to $695695.0 in 2023, then increased by 11.42% to $775147.0 in 2024, then increased by 10.32% to $855142.0 in 2025, then gained by 2.27% to $874564.0 in 2026.
• According to Business Quant data, Receivables - Other over the past three periods registered $874564.0, $855142.0, and $831458.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.